These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36576859)

  • 1. Replication Protein Rep Provides Selective Advantage to Viruses in the Presence of CRISPR-Cas Immunity.
    Zhang W; Bhoobalan-Chitty Y; Zhai X; Hui Y; Hansen LH; Deng L; Peng X
    CRISPR J; 2023 Feb; 6(1):32-42. PubMed ID: 36576859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CRISPR-Based and CRISPR-Based Genome Editing of
    Mayo-Muñoz D; He F; Jørgensen JB; Madsen PK; Bhoobalan-Chitty Y; Peng X
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30544778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance of Sulfolobus SMV1 virus to the immunity of I-A and III-B CRISPR-Cas systems in Sulfolobus islandicus.
    Guo T; Han W; She Q
    RNA Biol; 2019 Apr; 16(4):549-556. PubMed ID: 29629622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploitation of the Cooperative Behaviors of Anti-CRISPR Phages.
    Chevallereau A; Meaden S; Fradet O; Landsberger M; Maestri A; Biswas A; Gandon S; van Houte S; Westra ER
    Cell Host Microbe; 2020 Feb; 27(2):189-198.e6. PubMed ID: 31901522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable maintenance of the rudivirus SIRV3 in a carrier state in Sulfolobus islandicus despite activation of the CRISPR-Cas immune response by a second virus SMV1.
    Papathanasiou P; Erdmann S; Leon-Sobrino C; Sharma K; Urlaub H; Garrett RA; Peng X
    RNA Biol; 2019 Apr; 16(4):557-565. PubMed ID: 30146914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Widespread anti-CRISPR proteins in virulent bacteriophages inhibit a range of Cas9 proteins.
    Hynes AP; Rousseau GM; Agudelo D; Goulet A; Amigues B; Loehr J; Romero DA; Fremaux C; Horvath P; Doyon Y; Cambillau C; Moineau S
    Nat Commun; 2018 Jul; 9(1):2919. PubMed ID: 30046034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CRISPR Proteins in Archaea.
    Peng X; Mayo-Muñoz D; Bhoobalan-Chitty Y; Martínez-Álvarez L
    Trends Microbiol; 2020 Nov; 28(11):913-921. PubMed ID: 32499102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CRISPR proteins encoded by archaeal lytic viruses inhibit subtype I-D immunity.
    He F; Bhoobalan-Chitty Y; Van LB; Kjeldsen AL; Dedola M; Makarova KS; Koonin EV; Brodersen DE; Peng X
    Nat Microbiol; 2018 Apr; 3(4):461-469. PubMed ID: 29507349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Killer Archaea: Virus-Mediated Antagonism to CRISPR-Immune Populations Results in Emergent Virus-Host Mutualism.
    DeWerff SJ; Bautista MA; Pauly M; Zhang C; Whitaker RJ
    mBio; 2020 Apr; 11(2):. PubMed ID: 32345641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas based targeting of host and viral genes as an antiviral strategy.
    Koujah L; Shukla D; Naqvi AR
    Semin Cell Dev Biol; 2019 Dec; 96():53-64. PubMed ID: 30953741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of Acr-mediated immunosuppression in
    Pons BJ; Westra ER; van Houte S
    MethodsX; 2023; 10():101941. PubMed ID: 36504499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Strategies of Clustered Regularly Interspaced Palindromic Repeats-Cas Systems for Different Viral Infections.
    Wahid B; Usman S; Ali A; Saleem K; Rafique S; Naz Z; Ahsan Ashfaq H; Idrees M
    Viral Immunol; 2017 Oct; 30(8):552-559. PubMed ID: 28825529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cas4 Nucleases Can Effect Specific Integration of CRISPR Spacers.
    Zhang Z; Pan S; Liu T; Li Y; Peng N
    J Bacteriol; 2019 Jun; 201(12):. PubMed ID: 30936372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing Type I and Type III CRISPR-Cas systems for genome editing.
    Li Y; Pan S; Zhang Y; Ren M; Feng M; Peng N; Chen L; Liang YX; She Q
    Nucleic Acids Res; 2016 Feb; 44(4):e34. PubMed ID: 26467477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for inhibition of type III-B CRISPR-Cas by an archaeal viral anti-CRISPR protein.
    Lin J; Alfastsen L; Bhoobalan-Chitty Y; Peng X
    Cell Host Microbe; 2023 Nov; 31(11):1837-1849.e5. PubMed ID: 37909049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
    Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
    mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversified local CRISPR-Cas immunity to viruses of Sulfolobus islandicus.
    Pauly MD; Bautista MA; Black JA; Whitaker RJ
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180093. PubMed ID: 30905292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome changes in STSV2-infected Sulfolobus islandicus REY15A undergoing continuous CRISPR spacer acquisition.
    León-Sobrino C; Kot WP; Garrett RA
    Mol Microbiol; 2016 Feb; 99(4):719-28. PubMed ID: 26514343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic determinants of PAM-dependent DNA targeting and pre-crRNA processing in Sulfolobus islandicus.
    Peng W; Li H; Hallstrøm S; Peng N; Liang YX; She Q
    RNA Biol; 2013 May; 10(5):738-48. PubMed ID: 23392249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keeping crispr in check: diverse mechanisms of phage-encoded anti-crisprs.
    Trasanidou D; Gerós AS; Mohanraju P; Nieuwenweg AC; Nobrega FL; Staals RHJ
    FEMS Microbiol Lett; 2019 May; 366(9):. PubMed ID: 31077304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.